Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarlota Mesaros

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Acta Neurologica Belgica|March 6, 2013
Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year studyDarija Kisic Tepavcevic, Tatjana Pekmezovic, Nebojsa Stojsavljevic, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 30, 2022
Occurrence of malignant diseases in patients with multiple sclerosis: population-based MS Registry dataGorica Maric, Tatjana Pekmezovic, Sarlota Mesaros, et al.
The European Journal of Neuroscience|July 6, 2010
The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL studyFederica Agosta, Vladimir S Kostić, Sebastiano Galantucci, et al.
Journal of Neurology|July 30, 2021
Application of deep-learning to the seronegative side of the NMO spectrumLaura Cacciaguerra, Loredana Storelli, Marta Radaelli, et al.
Journal of Neuroimmunology|October 7, 2015
Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing-remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-upEmina Milosevic, Irena Dujmovic, Milos Markovic, et al.
Muscle & Nerve|October 2, 2015
Brain sonography insight into the midbrain in myotonic dystrophy type 2Vidosava Rakocevic-Stojanovic, Stojan Peric, Dusanka Savic-Pavicevic, et al.
Human Brain Mapping|August 10, 2017
Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year studyPaolo Preziosa, Elisabetta Pagani, Sarlota Mesaros, et al.
Radiology|September 9, 2015
Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging StudyMaria A Rocca, Paolo Preziosa, Sarlota Mesaros, et al.
Multiple Sclerosis and Related Disorders|July 23, 2021
Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapiesJelena Drulovic, Jovana Ivanovic, Vanja Martinovic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2019
Functional brain connectivity abnormalities and cognitive deficits in neuromyelitis optica spectrum disorderFilippo Savoldi, Maria A Rocca, Paola Valsasina, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Acta Neurologica Belgica|March 6, 2013
Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year studyDarija Kisic Tepavcevic, Tatjana Pekmezovic, Nebojsa Stojsavljevic, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 30, 2022
Occurrence of malignant diseases in patients with multiple sclerosis: population-based MS Registry dataGorica Maric, Tatjana Pekmezovic, Sarlota Mesaros, et al.
The European Journal of Neuroscience|July 6, 2010
The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL studyFederica Agosta, Vladimir S Kostić, Sebastiano Galantucci, et al.
Journal of Neurology|July 30, 2021
Application of deep-learning to the seronegative side of the NMO spectrumLaura Cacciaguerra, Loredana Storelli, Marta Radaelli, et al.
Journal of Neuroimmunology|October 7, 2015
Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing-remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-upEmina Milosevic, Irena Dujmovic, Milos Markovic, et al.
Muscle & Nerve|October 2, 2015
Brain sonography insight into the midbrain in myotonic dystrophy type 2Vidosava Rakocevic-Stojanovic, Stojan Peric, Dusanka Savic-Pavicevic, et al.
Human Brain Mapping|August 10, 2017
Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year studyPaolo Preziosa, Elisabetta Pagani, Sarlota Mesaros, et al.
Radiology|September 9, 2015
Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging StudyMaria A Rocca, Paolo Preziosa, Sarlota Mesaros, et al.
Multiple Sclerosis and Related Disorders|July 23, 2021
Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapiesJelena Drulovic, Jovana Ivanovic, Vanja Martinovic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2019
Functional brain connectivity abnormalities and cognitive deficits in neuromyelitis optica spectrum disorderFilippo Savoldi, Maria A Rocca, Paola Valsasina, et al.
Pageof 8